[[STAGE]] Parp inhibitors in early breast cancer. A new era in BRCA mutation carriers

Parp inhibitors in early breast cancer. A new era in BRCA mutation carriers

E-session 606002

Expert

Karen Gelmon

BC Cancer
Vancouver, BC, Canada

Discussant

Simona Volovat

Medical Oncologist
Grigore T. Popa University of Medicine
Iasi, Romania

This e-Session is part of the following pathway(s):

Mar 2022

ESCO is the College of the European School of Oncology for ESO students offering a structured educational pathway to enhance their oncology careers.

The e-ESO e-Sessions are part of the Master-Online Study Program Advanced Oncology of Ulm University
www.uni-ulm.de

Oncology education together via social media